TopiVert demonstrates proof of concept in Phase 1/2a study of TOP1630 in the treatment of dry eye syndrome
Digging deeper into the types of patients who get dry eye and the situations that can bring it on.
Allergan Granted Marketing Authorization by the FDA for TrueTear™, the First Intranasal Neurostimulating Device Proven to Temporarily Increase Tear Production
AXIM Biotech Retains Ora to Manage Upcoming Product Development and Clinical Trials on Glaucoma and Dry Eye Indications
Ophthalmic Product Development Insights
How this particular type of gene editing works and a discussion of its potential uses in the future.
A look at ocular/nasal interactions and how they can affect our
Symptom scores can be helpful when treating dry eye, but
constructing good questionnaires can be a challenge.
The purpose of any scale is to provide a means to measure a trait, a physical change or any parameter not readily amenable to direct quantitation.